Evidence map›Paper›PMID 27475969›Full record

GuidelineThe Journal of urology2016

Design and Methodological Considerations of the Centers for Disease Control and Prevention Urologic and Renal Protocol for the Newborn and Young Child with Spina Bifida.

Jonathan C Routh, Earl Y Cheng, J Christopher Austin, Michelle A Baum, Patricio C Gargollo, Richard W Grady, Adrienne R Herron, Steven S Kim, Shelly J King, Chester J Koh and 10 more

Registry-linked trialOpen access · greenAbstract readPractice Guideline
In one paragraph

Guideline in The Journal of urology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03959163 (The Validity of the Quick Renal MRI in Pediatric Kidney Disease), which is not on this map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
22.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03959163 narecruitingnot on this mapstarted 2019, after this paper: background citation

The Validity of the Quick Renal MRI in Pediatric Kidney Disease

TypeinterventionalSponsorUniversity of Wisconsin, MadisonRan2019 to 2025Enrolled100ConditionsPyelonephritis, Pyelonephritis Acute, Renal SclerosisArmsQuick MRI
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 111 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 16 institutions in 1 country.

Jonathan C RouthDivision of Urology, Duke University Medical Center, Durham, North Carolina. Electronic address: jonathan.routh@duke.edu.
Earl Y ChengDivision of Urology, Lurie Children's Hospital of Chicago, Chicago, Illinois.
J Christopher AustinDepartment of Urology, Oregon Health Sciences University, Portland, Oregon.
Michelle A BaumDivision of Nephrology, Boston Children's Hospital, Boston, Massachusetts.
Patricio C GargolloDepartment of Urology, Mayo Clinic, Rochester, Minnesota.
Richard W GradyDepartment of Urology, Seattle Children's Hospital, Seattle, Washington.
Adrienne R HerronNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
Steven S KimDivision of Urology, Children's Hospital Los Angeles, Los Angeles, California.
Shelly J KingDepartment of Urology, Riley Hospital for Children, Indianapolis, Indiana.
Chester J KohDivision of Urology, Texas Children's Hospital/Baylor College of Medicine, Houston, Texas.
Pangaja ParamsothyNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
Lisa RamanSpina Bifida Association, Arlington, Virginia.
Michael S SchechterDivision of Pediatric Pulmonary Medicine, Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, Virginia.
Kathryn A SmithDivision of General Pediatrics, Children's Hospital Los Angeles, Los Angeles, California.
Stacy T TanakaDivision of Pediatric Urology, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee.
Judy K ThibadeauNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
William O WalkerDivision of Developmental Medicine, Seattle Children's Hospital, Seattle, Washington.
M Chad WallisDivision of Urology, Primary Children's Hospital, Salt Lake City, Utah.
John S WienerDivision of Urology, Duke University Medical Center, Durham, North Carolina.
David B JosephDepartment of Urology, University of Alabama-Birmingham, Birmingham, Alabama.
Centers for Disease Control and Prevention · USChildren's Hospital of Los Angeles · USDuke Medical Center · USSeattle Children's Hospital · USBaylor College of Medicine · USBoston Children's Hospital · USChildren's Hospital of Richmond at VCU · USLurie Children's Hospital · USMayo Clinic · USMonroe Carell Jr. Children's Hospital · USNational Center on Birth Defects and Developmental Disabilities · USOregon Health & Science University · USPrimary Children's Hospital · USRiley Hospital for Children · USSpina Bifida Association · USUniversity of Alabama at Birmingham · US

Funding

Research Approaches to Improve the Care and Outcomes of People Living with Spina BifidaU01DD001265 · DD · BAYLOR COLLEGE OF MEDICINE · PI CASTILLO, HEIDI, TU, DUONG DAI · 2019 to 2023
$456k
Comp B-Texas Children's Hospital and Baylor Coll of Med Spina Bifida RegistryU01DD001072 · DD · BAYLOR COLLEGE OF MEDICINE · PI CASTILLO, HEIDI, KOH, CHESTER · 2014 to 2018
$327k
Comp B-Primary Children's Hospital Spina Bifida Patient RegistryU01DD001062 · DD · IHC HEALTH SERVICES, INC. · PI PETERSON, PAULA RUTH · 2014 to 2018
$327k
Urologic Management to Preserve Renal Function Protocol - Component CU01DD001276 · DD · DUKE UNIVERSITY · PI ROUTH, JONATHAN C, WIENER, JOHN SAMUEL · 2019 to 2023
$141k
Comp C-National Spina Bifida Patient Registry/Urological Component U01DD001060 · DD · IHC HEALTH SERVICES, INC. · PI PETERSON, PAULA RUTH · 2014 to 2018
$102k
Comp C-Urologic Management to Preserve Renal Function Protocol - Duke ProjectU01DD001087 · DD · DUKE UNIVERSITY · PI WIENER, JOHN SAMUEL · 2014 to 2018
$102k
Comp C-National SB Urologic Protocol at Vanderbilt Children's HospitalU01DD001075 · DD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI TANAKA, STACY T · 2014 to 2018
$102k
Comp C-Urologic Management for Young Children with SB at TCH/BCMU01DD001070 · DD · BAYLOR COLLEGE OF MEDICINE · PI CASTILLO, HEIDI, TU, DUONG DAI · 2014 to 2018
$102k
ACL HHS U01DD001087Intramural CDC HHS CC999999NCBDD CDC HHS U01 DD001060NCBDD CDC HHS U01 DD001062NCBDD CDC HHS U01 DD001070NCBDD CDC HHS U01 DD001072NCBDD CDC HHS U01 DD001075NCBDD CDC HHS U01 DD001087NCBDD CDC HHS U01 DD001263NCBDD CDC HHS U01 DD001265NCBDD CDC HHS U01 DD001276
6 · The paper itself

Abstract

purposeCare of children with spina bifida has significantly advanced in the last half century, resulting in gains in longevity and quality of life for affected children and caregivers. Bladder dysfunction is the norm in patients with spina bifida and may result in infection, renal scarring and chronic kidney disease. However, the optimal urological management for spina bifida related bladder dysfunction is unknown. MATERIALS AND

methodsIn 2012 the Centers for Disease Control and Prevention convened a working group composed of pediatric urologists, nephrologists, epidemiologists, methodologists, community advocates and Centers for Disease Control and Prevention personnel to develop a protocol to optimize urological care of children with spina bifida from the newborn period through age 5 years.

resultsAn iterative quality improvement protocol was selected. In this model participating institutions agree to prospectively treat all newborns with spina bifida using a single consensus based protocol. During the 5-year study period outcomes will be routinely assessed and the protocol adjusted as needed to optimize patient and process outcomes. Primary study outcomes include urinary tract infections, renal scarring, renal function and bladder characteristics. The protocol specifies the timing and use of testing (eg ultrasonography, urodynamics) and interventions (eg intermittent catheterization, prophylactic antibiotics, antimuscarinic medications). Starting in 2014 the Centers for Disease Control and Prevention began funding 9 study sites to implement and evaluate the protocol.

conclusionsThe Centers for Disease Control and Prevention Urologic and Renal Protocol for the Newborn and Young Child with Spina Bifida began accruing patients in 2015. Assessment in the first 5 years will focus on urinary tract infections, renal function, renal scarring and clinical process improvements.

Indexed as

Centers for Disease Control and Prevention, U.S.Child, PreschoolClinical ProtocolsHumansInfantInfant, NewbornSpinal DysraphismUnited StatesUrinary Bladder, Neurogenicneurogenicpediatricsspinal dysraphismurinary bladderurology

Identifiers

PMID27475969
PMCPMC5201100
OpenAlexW2534843150

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.